technetium tc 99m diphosphonate has been researched along with risedronic acid in 1 studies
Studies (technetium tc 99m diphosphonate) | Trials (technetium tc 99m diphosphonate) | Recent Studies (post-2010) (technetium tc 99m diphosphonate) | Studies (risedronic acid) | Trials (risedronic acid) | Recent Studies (post-2010) (risedronic acid) |
---|---|---|---|---|---|
230 | 10 | 16 | 1,318 | 290 | 487 |
Protein | Taxonomy | technetium tc 99m diphosphonate (IC50) | risedronic acid (IC50) |
---|---|---|---|
Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.1104 | |
Farnesyl pyrophosphate synthase | Leishmania donovani | 0.1699 | |
Farnesyl diphosphate synthase | Toxoplasma gondii | 0.074 | |
Farnesyl diphosphate synthase | Trypanosoma cruzi | 0.027 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, Y; Funayama, H; Kawamura, H; Oizumi, T; Sugawara, S; Yamaguchi, K | 1 |
1 other study(ies) available for technetium tc 99m diphosphonate and risedronic acid
Article | Year |
---|---|
Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
Topics: Aged; Aged, 80 and over; Binding, Competitive; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Inflammation Mediators; Lipopolysaccharides; Mandibular Diseases; Nitrogen; Osteomyelitis; Osteonecrosis; Osteoporosis, Postmenopausal; Radionuclide Imaging; Radiopharmaceuticals; Risedronic Acid; Technetium Compounds; Tooth Extraction | 2010 |